Levetiracetam Tillomed

Levetiracetam, the active ingredient in Levetiracetam Tillomed, is an anticonvulsant presented as an oral formulation for oral use. It is employed to control various seizure types in patients diagnosed with epilepsy. Levetiracetam Tillomed is indicated for partial‑onset, generalized tonic‑clonic and myoclonic seizures and is prescribed by healthcare professionals based on individual therapeutic needs.

GNH USA supplies Levetiracetam Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that modulates neuronal excitability to prevent seizure activity.

- Partial‑onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps achieve seizure control in primary generalized epilepsy. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with myoclonic epilepsy.

Levetiracetam is generally well tolerated, but a range of adverse reactions has been reported.

Common Side Effects: - Dizziness: mild to moderate sensation of light‑headedness. - Fatigue: persistent tiredness not related to activity level. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate cranial pain. - Irritability: mood changes including agitation. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Depression or suicidal thoughts: new or worsening mood disturbances. - Blood dyscrasias: including leukopenia or thrombocytopenia. - Allergic reactions: rash, angioedema, or anaphylaxis. - Multi‑organ involvement: rare cases of hepatic or renal impairment. - Respiratory depression: when combined with other CNS depressants.

When prescribing levetiracetam, clinicians should consider several safety factors.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests periodically. - Psychiatric history: observe for mood changes or depressive symptoms. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam may interact with other medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, reducing levetiracetam plasma levels. - Phenytoin: increases clearance, potentially decreasing efficacy. - Phenobarbital: accelerates elimination, leading to sub‑therapeutic concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptics: dose adjustments may be needed to maintain seizure control. - Renal excretion inhibitors: could raise levetiracetam exposure, requiring monitoring.